Clinical Trial Update: A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients [Phase 4]

View source ↗

Summary

A Phase 4 pragmatic clinical trial evaluating whether vancomycin plus piperacillin-tazobactam increases the risk of acute kidney injury compared with vancomycin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Cefepime (cefepime)
• Piperacillin/tazobactam (Piperacillin/tazobactam)
• Vancomycin (vancomycin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Acute Kidney Injury | Phase 4 | Status: RECRUITING